IL1B and myeloproliferative neoplasm: In MPN patients with homozygous IL-1β polymorphisms having an elevated IL-1β production, it is not surprising to see treatment of anemic patients with CH mutations by anti-IL-1β antibody showed favorable hemoglobin responses [38].